GlassScriptPhysician profile
David James Peters
NPI 1942205257
$1,138.36
in general payments reported to CMS, 2019-2025
19 companies · $325 in 2025
The $325 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $49.92 · 2021: $101 · 2022: $226 · 2023: $74.65 · 2024: $222 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $621.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $259.71 | 2021-2025 | |
| Ardelyx, INC. | $150.79 | 2022-2025 | Ibsrela |
| Takeda Pharmaceuticals U.S.A., INC. | $104.11 | 2019-2025 | Entyvio, Eohilia |
| Janssen Biotech, INC. | $96.45 | 2020-2024 | Stelara, Tremfya |
| Ferring Pharmaceuticals INC. | $95.47 | 2023-2025 | Rebyota |
| Braintree Laboratories, INC. | $70.72 | 2020-2022 | |
| Genzyme Corporation | $70.63 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.53 | 2019 | |
| Celgene Corporation | $39.26 | 2021-2023 | Zeposia |
| Shionogi INC | $27.00 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $25.34 | 2024 | Iqirvo |
| Micro-Tech Endoscopy USA, INC. | $23.17 | 2025 | Lesionhunter |
| Evoke Pharma, INC. | $22.83 | 2021 | |
| Redhill Biopharma INC. | $22.35 | 2021 | |
| Medtronic, INC. | $21.40 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $16.55 | 2019 | |
| Portola Pharmaceuticals, LLC | $15.90 | 2019 | |
| Mauna Kea Technologies, INC. | $14.93 | 2021 | |
| Pfizer INC. | $13.22 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Peters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.